RESPIVANT SCIENCES HOLDINGS LTD.

Dissolved London

Activities of other holding companies n.e.c.

2 employees website.com
Activities of other holding companies n.e.c.
R

RESPIVANT SCIENCES HOLDINGS LTD.

Activities of other holding companies n.e.c.

Founded 13 Aug 2018 Dissolved London, United Kingdom 2 employees website.com
Activities of other holding companies n.e.c.
Accounts
Confirmation Submitted 16 Aug 2023 Next due 26 Aug 2024 21 months overdue
Net assets £1M £1M 2021 year on year
Total assets £1M £1M 2021 year on year
Total Liabilities £75K £21K 2021 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

7th Floor 50 Broadway London SW1H 0DB United Kingdom

Full company profile for RESPIVANT SCIENCES HOLDINGS LTD. (11513022), a dissolved company based in London, United Kingdom. Incorporated 13 Aug 2018. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2021
Type Total Exemption Full
Next accounts 31 December 2022
Due by 30 September 2023 9 months

Net Assets, Total Assets & Total Liabilities (2018–2021)

Cash in Bank

N/A

Net Assets

£1.09M

Increased by £1.10M (+41211%)

Total Liabilities

£74.65k

Increased by £20.97k (+39%)

Turnover

N/A

Employees

2

Debt Ratio

6%

Decreased by 99 (-94%)

Financial History

Revenue, profit, EBITDA and key financial figures

2021
Dec Year End
2020
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

5 Allotments 5 Shares £100k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
31 Mar 20221$15k$15k
31 Mar 20211$13k$13k
31 Mar 20211$12k$12k
30 Mar 20201$30k$30k
29 Mar 20191$30k$30k

Officers

Officers

3 active
Status
Emma Carys PriceDirectorBritishUnited Kingdom326 Oct 2023Active
Lee Francis MooreDirectorBritishUnited Kingdom4513 Aug 2018Active
Vistra Cosec LimitedCorporate-secretaryUnited KingdomUnknown13 Aug 2018Active

Shareholders

Shareholders (1)

Respivant Sciences Ltd.
100.0%
20,565

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Roivant Sciences Ltd.

Bermuda

Active
Notified 1 Oct 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

RESPIVANT SCIENCES HOLDINGS LTD. Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Sept 2024GazetteGazette Dissolved Voluntary
25 Jun 2024GazetteGazette Notice Voluntary
14 Jun 2024DissolutionDissolution Application Strike Off Company
11 Apr 2024ResolutionResolutions
11 Apr 2024InsolvencySolvency Statement dated 05/04/24
10 Sept 2024 Gazette

Gazette Dissolved Voluntary

25 Jun 2024 Gazette

Gazette Notice Voluntary

14 Jun 2024 Dissolution

Dissolution Application Strike Off Company

11 Apr 2024 Resolution

Resolutions

11 Apr 2024 Insolvency

Solvency Statement dated 05/04/24

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

1 years ago on 10 Sept 2024

Gazette Notice Voluntary

1 years ago on 25 Jun 2024

Dissolution Application Strike Off Company

1 years ago on 14 Jun 2024

Resolutions

2 years ago on 11 Apr 2024

Solvency Statement dated 05/04/24

2 years ago on 11 Apr 2024